TG Therapeutics | TGTX - 营业费用



金融业
股票价格
USD
资产
USD 1.64B
现金及等价物
USD 612.25M
销售成本
USD 41.19M
流动资产
USD 1.15B
流动负债
USD 268.49M
债务
USD 754.44M
EBIT
USD 21.67M
EBITDA
USD 26.9M
员工
338
EPS每股收益
USD 0.05
股本和储备
USD 604.08M
销售毛利
USD 199.14M
债务利息支出
USD 16.57M
贷款资金
USD 745.39M
市值
USD 8.44B
净收入
USD 7.78M
营业费用
USD 218.66M
营业利润
USD 21.67M
普通股股本
USD 153.08M
PE价格收益
19.64
税前利润
USD 10.23M
销售收入
USD 240.34M
销售和管理费用
USD 62.33M
股票
USD 147.97M
贸易债权人
USD 213.69M
应收帐款人
USD 401.57M


营业费用 更改 日
AbbVie USD 10.27B 1000K 2026-06
Alaunos Therapeutics USD 1.01M 175K 2026-03
Amgen USD 11.69B 6.9B 2026-06
Ardelyx USD 127.27M 7.15M 2026-03
Arrowhead Research USD 245.35M 30.35M 2026-06
Bayer EUR 10.04B 168M 2026-06
Biogen USD 2.98B 1.02B 2026-06
Corcept Therapeutics USD 214.85M 343K 2026-06
Curis USD 11.52M 2.5M 2026-03
Gilead Sciences USD 3.95B 19.57B 2026-06
J&J USD 17.83B 388M 2026-06
Karyopharm Therapeutics USD 61.83M 9.9M 2026-03
Novartis USD 10.2B 912M 2026-06
Novavax USD 126.2M 23.62M 2025-12
PTC Therapeutics USD 226.66M 19.64M 2026-03
Puma Biotechnology USD 49.26M 3.2M 2024-06
Regeneron Pharmaceuticals USD 31.71B 287.8M 2026-06
Roche Holding CHF 18.9B 2.12B 2026-06
TG Therapeutics USD 218.66M 48.54M 2026-06
Verastem USD 63.57M 4.56M 2026-03
Vertex Pharmaceuticals USD 2.07B 217.1M 2026-06